Greater Glasgow and Clyde Medicines

Click on the following link (on StaffNet) to access new and updated clinical guidelines including NHSGGC, SIGN and NICE guidelines. 

This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines assessed by SMC and considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.

For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary

Medicines reconciliation- Mental Health Clozapine & antipsychotic long acting injections (depot) Key points The Emergency Care Summary (ECS) for patients with a diagnosis of schizophrenia may show n...

  Systemically administered VEGF pathway inhibitors: risk of aneurysm and arte...

Quetiapine IR preferred choice Key points The NHSGGC Prescribing Manage...

Click on the following link (on StaffNet) to access new and updated clinical guidelines including NHSGGC, SIGN and NICE guidelines. 

The 

Click on the following links to access NHSGGC COVID-19 clinical guidelines published between 22nd June and 10th July 2020. Please note, all the links are on StaffNet and require NHSGGC network access.

Click on the following link to access new and updated clinical guidelines including NHSGGC, SIGN and NICE guidelines. Please note, all the links are on StaffNet and require NHSGGC network access.

Cyproterone acetate: new advice to minimise risk of meningioma